WT1 and pancreatic neoplasm: To determine whether degrasyn‐induced anti‐cancer activity depends on the degradation of WT1 protein, pancreatic cancer cells were transduced with MSCV‐WT1 or MSCV‐NC followed by the treatment of degrasyn.